… assessments, joint clinical assessments will also be carried out for advanced therapy medicinal
products… joint clinical assessments will be performed for all medicinal products approved …

… the evaluation by the EMA Committee for Advanced Therapies (… Health Technology
Assessment (HTA) body must wait for the EMA opinion before assessing the risk/benefit of a therapy, …

… a drug or procedure and the patient pays the remainder, and Health Technology Assessment
(… between healthcare payers and medical product manufacturers are futile if capturing and …

… advanced therapy medicinal products (ATMPs) is a current challenge for their reimbursement
in health … NHAs reports, such as health technology assessments (HTAs) and other official …

… Prequalification of medicines is a service WHO provides to assess the quality, safety and
efficacy of medicinal products for a number of priority diseases. Prequalification is intended to …

… Advanced therapy medicinal products (ATMPs) have a massive potential to address
existing unmet medical needs. Specifically, gene therapy medicinal products (GTMPs) may …

… enable rapid, EU-wide authorisation of medicinal products. … health technology assessment
and amending Directive 2011/24/EU. European Commission, Directorate-General for Health …

… all pharmaceutical products together is by calling them “health technology.” This includes …
guidelines for the rational use of drugs and other pharmaceutical products. WHO uses the term …

… advanced therapy medicinal products … These products were called advanced therapy
medicinal products (… cell-based/gene therapy medicinal products places special requirements on …

… advanced therapies. This work explains that reinventing an adoption route for Advanced
Therapy Medicinal Products … that shift influence from Health Technology Assessment (HTAs) to …